# Passage BIO, Inc.: Form 8-K, filed Mar 15, 2022

- Company: [Passage BIO, Inc.](/companies/pasg.md) (CIK 1787297)
- Form: 8-K
- Filed: 2022-03-15
- Accepted by EDGAR: Mar 15, 2022, 07:10 ET
- Period: 2022-03-15
- Accession: 0001104659-22-033615
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1787297/000110465922033615/tm228940d2_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1787297/000110465922033615/

## Items reported

- Item 8.01: Other events

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1787297/000110465922033615/tm228940d2_8k.htm

Filed Mar 15, 2022.
Source: SEC EDGAR, the filing index for accession 0001104659-22-033615. Last ingested by Listed: Nov 10, 2026, 16:52 ET. No prices; not investment advice.
